TrialPloS one2019

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Stéphane Pillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.